Join to view full profile
Rockville Pike# 8901Bethesda, MD 20889
Phone+1 301-295-6230
Fax+1 301-295-5928
Dr. Lipkowitz is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1984 - 1987
Weill Cornell MedicineClass of 1984
Certifications & Licensure
MD State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model.Dinesh Kumar, Vanesa Silvestri, Elijah F Edmondson, Imran Khan, Wei Zhang
Cancer Letters. 2026-08-24 - Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.Yonit A Addissie, Yoshimi E Greer, Jayakumar Nair, Stanley Lipkowitz
Breast Cancer Research. 2026-08-14 - AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology.Eldad D Shulman, Emma M Campagnolo, Roshan Lodha, Youngmin Chung, Amos Stemmer
Cell. 2026-07-09
Press Mentions
Behind the Study: How ONC201 Kills Breast Cancer CellsApril 22nd, 2022
Panel Tells FDA to Keep Atezolizumab Approval in TNBCApril 28th, 2021
ONC201 Kills Breast Cancer Cells in Vitro by Targeting MitochondriaMay 9th, 2018
Grant Support
- Identification Of Molecular Targets In Triple-Negative Breast CancerDivision Of Basic Sciences - Nci2009
- Trail-Induced Cell Death In Breast Cancer CellsNational Cancer Institute2008
- Identification Of Molecular Targets In Triple-Negative Breast CancerNational Cancer Institute2008
- Signal Transduction In Epithelial Cancer CellsNational Cancer Institute2007
- Signal Transduction In Epithelial Cancer CellsDivision Of Clinical Sciences - Nci2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










